Intralesional Meglumine Antimoniate for Treatment of Cutaneous Leishmaniasis Patients with Contraindication to Systemic Therapy from Rio de Janeiro (2000 to 2006)

We evaluated the effectiveness and safety of intralesional meglumine antimoniate (MA) in 24 not submitted to previous treatment patients with cutaneous leishmaniasis (CL) and with contraindication to systemic therapy. Each treatment consisted of one to four intralesional applications of MA at 15-day...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Vasconcellos, Érica de Camargo Ferreira e, Pimentel, Maria Inês Fernandes, Schubach, Armando de Oliveira, de Oliveira, Raquel de Vasconcellos Carvalhaes, Azeredo-Coutinho, Rilza Beatriz, Silva, Fátima da Conceição, Salgueiro, Mariza de Matos, Moreira, João Soares, Madeira, Maria de Fátima, Baptista, Cibele, Valete-Rosalino, Cláudia Maria
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: The American Society of Tropical Medicine and Hygiene 2012
Θέματα:
Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414560/
https://ncbi.nlm.nih.gov/pubmed/22855754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2012.11-0612
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια